Charles Atwood is a Respiratory physician affiliated with University of Pittsburgh. OpenAlex indexes 104 publications with 3,257 citations (h-index 24); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3601 5th Ave
4th Floor Comprehensive Lung Center
Pittsburgh, PA 152133403
Telephone
412-648-6161Registry record last updated 20 Jul 2016.
Clinical trials
- Clinical Efficacy in Relief of Dyspnea by HVNI: Evaluation of New Device Equivalence
Sponsor: Vapotherm, Inc.
- Clinical Efficacy in Relief of Dyspnea by HVNI: Evaluation of New Cannulae Designs
Sponsor: Vapotherm, Inc.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- JAZZ PHARMACEUTICALS INC.Program year20252 payments
- Paratek Pharmaceuticals, Inc.Program year20231 payment
- IDORSIA PHARMACEUTICALS US INCProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
78.6%Central Nervous System Stimulant20.4%Dextroamphetamine-Amphetamine62%Dextroamphetamine-Amphet Er20%Methylphenidate Hcl18%Part D<11 patientsBenzodiazepine18.6%Clonazepam50%Temazepam50%Part D<11 patients+ 7 more classes in this area
Respiratory
21.4%Corticosteroid13.3%Breo Ellipta56%Fluticasone Propionate44%Part D<11 patientsbeta2-Adrenergic Agonist8%Albuterol Sulfate Hfa100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Modified uvulopalatopharyngoplasty in modern obstructive sleep apnea treatment: a narrative review
Journal of Clinical Sleep Medicine
2025 - Travel Burden as a Measure of Healthcare Access and the Impact of Telehealth within the Veterans Health Administration
Journal of General Internal Medicine
2023 - Veterans Health Administration TeleSleep Enterprise-Wide Initiative 2017–2020: bringing sleep care to our nation’s veterans
Journal of Clinical Sleep Medicine
2023 - Sleep disorders among rural Veterans: Relative prevalence, comorbidities, and comparisons with urban Veterans
The Journal of Rural Health
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Toren Finkel, MD/PHD
University of Pittsburgh
Sally Wenzel, MD
University of Pittsburgh
Mary Phillips, MD
University of Pittsburgh
Jared Magnani, MD, MSc
University of Pittsburgh
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”